NASDAQ:IZTC - Nasdaq - US4618741098 - Common Stock - Currency: USD
NASDAQ:IZTC (2/11/2025, 8:00:02 PM)
16.5
+1 (+6.45%)
The current stock price of IZTC is 16.5 USD. In the past month the price increased by 50%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 18.04 | 327.31B | ||
AMGN | AMGEN INC | 13.94 | 155.58B | ||
GILD | GILEAD SCIENCES INC | 14.02 | 134.97B | ||
VRTX | VERTEX PHARMACEUTICALS INC | N/A | 113.22B | ||
REGN | REGENERON PHARMACEUTICALS | 11.5 | 55.03B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 40.38B | ||
ARGX | ARGENX SE - ADR | 94.29 | 33.10B | ||
ONC | BEONE MEDICINES LTD-ADR | 6.33 | 26.73B | ||
BNTX | BIONTECH SE-ADR | N/A | 25.61B | ||
NTRA | NATERA INC | N/A | 23.47B | ||
INSM | INSMED INC | N/A | 18.70B | ||
BIIB | BIOGEN INC | 8.03 | 18.62B |
Invizyne Technologies Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Monrovia California, California and currently employs 29 full-time employees. The company went IPO on 2024-11-13. Invizyne Technologies, Inc. is a biotechnology, pre-revenue, development stage company. The firm's cell-free technology expands its ability to perform enzyme-based conversions, guiding towards sustainable biomanufacturing. The firm is primarily engaged in the development of the SimplePath platform. Its SimplePath platform consists of a series of enzyme based biomanufacturing systems that leverage natural processes to perform complex chemical conversions that convert a starting material into a desired end-product. Each SimplePath system is composed of one or more modules which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company can provide solutions for natural ingredients (cannabinoids, flavor enhancers for food and beverage products, fragrances, nutraceuticals, organic compounds), pharmaceuticals (natural products with therapeutic properties) and chemicals (commodity chemicals, specialty chemicals, biofuels).
INVIZYNE TECHNOLOGIES INC
750 Royal Oaks Drive, Suite 106
Monrovia California CALIFORNIA US
Employees: 29
Phone: 16264151488
The current stock price of IZTC is 16.5 USD. The price increased by 6.45% in the last trading session.
The exchange symbol of INVIZYNE TECHNOLOGIES INC is IZTC and it is listed on the Nasdaq exchange.
IZTC stock is listed on the Nasdaq exchange.
INVIZYNE TECHNOLOGIES INC (IZTC) has a market capitalization of 134.15M USD. This makes IZTC a Micro Cap stock.
INVIZYNE TECHNOLOGIES INC (IZTC) currently has 29 employees.
INVIZYNE TECHNOLOGIES INC (IZTC) has a support level at 15.5 and a resistance level at 16.76. Check the full technical report for a detailed analysis of IZTC support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IZTC does not pay a dividend.
INVIZYNE TECHNOLOGIES INC (IZTC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.25).
ChartMill assigns a technical rating of 5 / 10 to IZTC.
ChartMill assigns a fundamental rating of 1 / 10 to IZTC. Both the profitability and financial health of IZTC have multiple concerns.
Over the last trailing twelve months IZTC reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS decreased by -46.01% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -57.25% | ||
ROE | N/A | ||
Debt/Equity | N/A |